Download PDF
Aktuelle Urol 2003; 34(2): 97-101
DOI: 10.1055/s-2003-38908
Übersichtsarbeit
© Georg Thieme Verlag Stuttgart · New York

Zystinurie - Zystinsteinleiden: Aktuelle Empfehlungen zur Diagnostik, Therapie und Nachsorge

Cystinuria - Cystine Stones: Recommendations for Diagnosis, Therapy and Follow-upT.  Knoll1 , V.  Janitzky2 , M.  S.  Michel1 , P.  Alken1 , K.  U.  Köhrmann1
  • 1Urologische Klinik, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1-3, 68135 Mannheim
  • 2Urologische Klinik, Johanniter-Krankenhaus Dohna-Heidenau GmbH
Further Information

Publication History

Publication Date:
23 April 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Zystinurie ist eine seltene hereditäre Erkrankung, welche zu rezidivierender Bildung von Zystinsteinen führt. Um eine progrediente Verschlechterung der Nierenfunktion durch intrarenale Steinmassen und wiederholte urologische Interventionen zu minimieren, sind regelmäßige Follow-up Untersuchungen und eine suffiziente Metaphylaxe notwendig. Beim Auftreten von behandlungsbedürftigen Konkrementen sollten wenig invasive Verfahren vorrangig eingesetzt werden, da sich diese Patienten während ihres Lebens mitunter multiplen Behandlungen unterziehen müssen. Diese Arbeit gibt, unter Berücksichtigung der aktuellen Literatur und den Richtlinien der Deutschen Gesellschaft für Urologie und der European Association of Urology, eine Übersicht zur Pathogenese, Diagnostik sowie Metaphylaxe und Therapie von Zystinurie und Zystinsteinen.

Abstract

Cystinuria, an autosomal-recessive disorder, is the cause of 1 - 2 % of all kidney stones observed in adults and about 10 % of those observed in infants. Despite increasing understanding of underlying pathomechanisms, patients still form recurrent stones and have to undergo repeated interventions with increasing risk of renal insufficiency. Dietary and medical metaphylaxis may lower the frequency of recurrent stones but are often not practiced. Regular follow-up examinations and optimal therapy significantly enlarge stone-free intervals. This review offers an overview of the underlying pathogenetic mechanisms as well as guidance for diagnosis, monitoring, metaphylaxis and therapy of cystinuria following the recommendations of the Deutsche Gesellschaft für Urologie (DGU) and the European Association of Urology (EAU).

Schlüsselwörter

Zystinurie - Metaphylaxe - Harnsteine

Key words

Cystinuria - urinary calculi - drug therapy

Literatur

  • 1 Barbey F, Joly D, Rieu P, Mejean A, Daudon M, Jungers P. Medical treatment of cystinuria: critical reappraisal of long-term results.  J Urol. 2000;  163 1419-1423
    PubMedGoogle Scholar
  • 2 Pierides A M. Clinical aspects of cystinuria.  Contrib Nephrol. 1997;  122 167-172
    PubMedGoogle Scholar
  • 3 Sakhaee K, Sutton R AL. Cystinuria. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds.) Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven 1996
    Google Scholar
  • 4 Leusmann D B, Blaschke R, Schmandt W. Results of 5,035 stone analyses: A contribution to epidemiology of urinary stone disease.  Scand J Urol Nephrol. 1990;  24 205-210
    CrossrefPubMedGoogle Scholar
  • 5 Gambaro G, Favaro S, D'Angelo A. The risk of renal failure in nephrolithiasis.  Am J Kidney Dis. 2001;  37 233-243
    PubMedGoogle Scholar
  • 6 Dent C E, Senior B. Studies on the treatment of cystinuria.  Br J Urol. 1955;  27 317-325
    PubMedGoogle Scholar
  • 7 Linari P, Marangella M, Fruttero B. The natural history of cystinuria: A 15 year follow-up in 106 patients. In: Smith LH, Robertson WG, Finlayson B (eds.): Urolithiasis: Clinical and Basic Research. New York: Plenum Press 1980: 145
    Google Scholar
  • 8 Bisceglia L, Calonge M J, Totaro A, Feliubadalo L, Melchionda S, Garcia J, Testar X, Gallucci M, Ponzone A, Zelante L, Zorzano A, Estivill X, Gasparini P, Nunes V, Palacin M. Localization by linkage analysis, of the cystinuria type III gene to chromosome 19q13.1.  Am J Hum Genet. 1997;  60 611-616
    PubMedGoogle Scholar
  • 9 Bisceglia L, Purroy J, Jimenez-Vidal M, d’Adamo A P, Rousaud F, Beccia E, Penza R, Rizzoni G, Gallucci M, Palacin M, Gasparini P, Nunes V, Zelante L. Cystinuria type I: identification of eight new mutations in SLC3A1.  Kidney Int. 2001;  59 1250
    CrossrefPubMedGoogle Scholar
  • 10 Ito H, Egoshi K, Mizoguchi K, Akakura K. Advances in genetic aspects of cystinuria.  Mol Urol. 2000;  4 403-408
    PubMedGoogle Scholar
  • 11 Leclerc D, Wu Q, Ellis J R, Goodyer P, Rozen R. Is the SLC7A10 gene on chromosome 19 a candidate locus for cystinuria?.  Mol Genet Metab. 2001;  73 333-339
    CrossrefPubMedGoogle Scholar
  • 12 Mizoguchi K, Cha S H, Chairoungdua A, Kim D K, Shigeta Y, Matsuo H, Fukushima J, Awa Y, Akakura K, Goya T, Ito H, Endou H, Kanai Y. Human cystinuria-related transporter: localization and functional characterization.  Kidney Int. 2001;  59 1821-1833
    CrossrefPubMedGoogle Scholar
  • 13 Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, Hershkovitz E. A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease.  Am J Hum Genet. 2001;  69 869-875
    CrossrefPubMedGoogle Scholar
  • 14 Pras E, Arber N, Aksentijevtich I, Katz G, Schpiro J M, Prosen L, Gruberg L, Harel D, Liberman U, Weissenbach J. Localization of gene causing cystinuria to chromosome 2p.  Nat Genet. 1994;  6 415-419
    PubMedGoogle Scholar
  • 15 Goodyer P, Boutros M, Rozen R. The molecular basis of cystinuria: an update.  Exp Nephrol. 2000;  8 123-127
    CrossrefPubMedGoogle Scholar
  • 16 Goodyer P, Saadi I, Ong P, Elkas G, Rozen R. Cystinuria subtype and the risk of nephrolithiasis.  Kidney Int. 1998;  54 56-61
    CrossrefPubMedGoogle Scholar
  • 17 Janitzky V, Berg W, Beck G. Zur Rezidivgefahr beim Cystinsteinleiden.  Urologe A. 1991;  30 (Suppl) A25
    PubMedGoogle Scholar
  • 18 Stoller M L, McDonald M W, Gentle D L, Bruce J, Low R K. Acalculous cystinuria.  J Endourol. 1997;  11 233-238
    PubMedGoogle Scholar
  • 19 Darnell J, Lodis H, Baltimore D. Molecules in cells. In: Molecular Cell Biology, ed. 2. New York: WH Freeman 1990: 43
    Google Scholar
  • 20 Evans W P, Resnick M I, Boyce W H. Homozygous cystinuria: Evaluation of 35 patients.  J Urol. 1982;  127 707-709
    PubMedGoogle Scholar
  • 21 Guillen M, Corella D, Cabello M L, Garcia A M, Hernandez-Yago J. Reference values of urinary excretion of cystine and dibasic aminoacids: classification of patients with cystinuria in the Valencian Community, Spain.  Clin Biochem. 1999;  32 25-30
    PubMedGoogle Scholar
  • 22 Nakagawa Y, Asplin J R, Goldfarb D S, Parks J H, Coe F L. Clinical use of cystine supersaturation measurements.  J Urol. 2000;  164 1481-1485
    PubMedGoogle Scholar
  • 23 Nakagawa Y, Coe F L. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference.  Clin Chim Acta. 1999;  289 57-68
    CrossrefPubMedGoogle Scholar
  • 24 Finocchiaro R, D'Eufemia P, Celli M, Zaccagnini M, Viozzi L, Troiani P, Mannarino O, Giardini O. Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure.  Urol Res. 1998;  26 401-405
    CrossrefPubMedGoogle Scholar
  • 25 Berg W, Janitzky V, Schubert J. Einfacher Schnelltest zur Bestimmung von Zystin im Urin.  Urologe B. 1998;  38 151-153
    CrossrefPubMedGoogle Scholar
  • 26 Deutsche Gesellschaft für Urologie . Arbeitskreis Harnsteine.  Urologe A. 1997;  588
    PubMedGoogle Scholar
  • 27 Monnens L A, Noordam K, Trijbels F. Necessary practical treatment of cystinuria at night.  Pediatr Nephrol. 2000;  14 1148-1149
    PubMedGoogle Scholar
  • 28 Jaeger P, Portmann L, Saunders A, Rosenberg L E, Thier S O. Anticystinuric effects of glutamine and dietary sodium restriction.  N Engl J Med. 1986;  143 1120-1123
    PubMedGoogle Scholar
  • 29 Pak C YC. Cystine lithiasis. In: Resnick MI, Pak CYC (eds.): Urolithiasis: A Medical and Surgical Reference. Philadelphia: WB Saunders 1994
    Google Scholar
  • 30 Wabner C L, Pak C Y. Effect of orange juice consumption on urinary stone risk factors.  J Urol. 1993;  149 1405-1408
    CrossrefPubMedGoogle Scholar
  • 31 Akakura K, Egoshi K, Ueda T, Nozumi K, Kotake T, Masai M, Ito H. The long-term outcome of cystinuria in Japan.  Urol Int. 1998;  61 86-89
    PubMedGoogle Scholar
  • 32 Chow G K, Streem S B. Contemporary urological intervention for cystinuric patients: immediate and long-term impact and implications.  J Urol. 1998;  160 341-344; discussion 344 - 345
    PubMedGoogle Scholar
  • 33 Harbar J A, Cusworth D C, Lawes L C, Wrong O M. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria.  J Urol. 1986;  136 146-149
    PubMedGoogle Scholar
  • 34 Lindell A, Dennberg T, Jeppsson J O, Tiselius H G. Measurement of diurnal variations in urinary cystine saturation.  Urol Res. 1995;  23 215-220
    CrossrefPubMedGoogle Scholar
  • 35 Pak C YC, Fuller C, Sakhae K, Zerwekh J H, Adams B V. Management of cystine nephrolithiasis with alpha-mercaptoproprionylglycin.  J Urol. 1986;  136 1003-1008
    PubMedGoogle Scholar
  • 36 Tekin A, Tekgul S, Atsu N, Sahin A, Bakkaloglu M. Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy.  J Urol. 2001;  165 2328-2330
    PubMedGoogle Scholar
  • 37 Cohen T D, Streem S B, Hall P. Clinical effect of captopril on the formation and growth of cystine calculi.  J Urol. 1995;  154 164-166
    PubMedGoogle Scholar
  • 38 Dahlberg P J, Jones J D. Cystinuria: failure of captopril to reduce cystine excretion.  Arch Intern Med. 1989;  149 713-717
    CrossrefPubMedGoogle Scholar
  • 39 Soland J A, Izzo Jr J L. Captopril reduces urinary cystine excretion in cystinuria.  Arch Int Med. 1987;  147 1409-1412
    PubMedGoogle Scholar
  • 40 Coe F L, Clark C, Parks J H, Asplin J R. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs.  J Urol. 2001;  166 688-693
    PubMedGoogle Scholar
  • 41 Asper R, Schmucki O. Cystinuria therapy by ascorbic acid.  Urol Int. 1982;  37 91-109
    PubMedGoogle Scholar
  • 42 Birwe H, Schneeberger W, Hesse A. Investigations of the efficacy of ascorbic acid therapy in cystinuria.  Urol Res. 1991;  19 199-201
    CrossrefPubMedGoogle Scholar
  • 43 Lux B, May P. Long-term observation of young cystinuric patients under ascorbic acid therapy.  Urol Int. 1983;  38 91-94
    PubMedGoogle Scholar
  • 44 Ragone R. Medical treatment of cystinuria with vitamin C.  Am J Kidney Dis. 2000;  5 1020
    PubMedGoogle Scholar
  • 45 Hess B, Ackermann D. Preventive measures in stones due to infection, uric acid and cystine.  Ther Umsch. 1992;  49 44-48
    PubMedGoogle Scholar
  • 46 Hess B. Prophylaxis of uric acid and cystine stones.  Urol Res. 1990;  18 Suppl. 1 S41-44
    CrossrefPubMedGoogle Scholar
  • 47 Harada M, Zhao-Ren K, Kamidono S. Experience with extracorporal shock wave lithotripsy for cystine calculi in 20 renal units.  J Endourol. 1992;  6 213-220
    PubMedGoogle Scholar
  • 48 Kachel T A, Vijan S R, Dretler S P. Endourological experience with cystine calculi and a treatment algorithm.  J Urol. 1991;  145 25-31
    PubMedGoogle Scholar
  • 49 Bhatta K M, Prien Jr E L, Dretler S P. Cystine calculi - rough and smooth: a new clinical distinction.  J Urol. 1989;  142 937-940
    PubMedGoogle Scholar
  • 50 Martin X, Salas M, Labeeuw M, Pozet N, Gelet A, Dubernard J M. Cystin stones: the impact of a new treatment.  Br J Urol. 1991;  68 234-239
    PubMedGoogle Scholar
  • 51 Rudnick D M, Bennett P M, Dretler S P. Retrograde renoscopic fragmentation of moderate-size (1.5 - 3.0 cm) renal cystine stones.  J Endourol. 1999;  13 483-485
    PubMedGoogle Scholar
  • 52 Schulze H, Haupt G, Piergiovanni M, Wisard M, von Niederhausern W, Senge T. The Swiss Lithoclast: A new device for endoscopic stone disintegration.  J Urol. 1993;  149 15-18
    PubMedGoogle Scholar
  • 53 Terai A, Takeuchi H, Terachi T, Kawakita M, Okada Y, Yoshida H, Isokawa Y, Taki Y, Oshida O. Intracorporal lithotripsy with the Swiss Lithoclast.  Int J Urol. 1996;  3 184-186
    PubMedGoogle Scholar
  • 54 Giddens J L, Grasso M. Retrograde ureteroscopic endopyelotomy using the holmium:YAG laser.  J Urol. 2000;  164 1509-1512
    PubMedGoogle Scholar
  • 55 Grasso M. Experience with the holmium laser as an endoscopic lithotrite.  Urology. 1996;  48 199-206
    CrossrefPubMedGoogle Scholar
  • 56 Razvi H A, Denstedt J D, Chun S S, Sales J L. Intracorporal lithotripsy with the holmium:YAG laser.  J Urol. 1996;  156 912-914
    PubMedGoogle Scholar
  • 57 Shroff S. Treatment of ureteric stones. Comparison of laser and pneumatic lithotripsy and intracorporal lithotripsy with the Swiss Lithoclast.  Br J Urol. 1995;  75 810
    PubMedGoogle Scholar
  • 58 Schmidt J, Madersbacher S, Hochreiter W W, Thalmann G N, Studer U E. Simultaneous replacement of both ureters with small intestine in a woman with cystinuria.  J Urol. 2001;  166 2315-2316
    PubMedGoogle Scholar

Dr. T. Knoll

Urologische Universitätsklinik

Theodor-Kutzer-Ufer 1-3

68135 Mannheim

Phone: 0621/383-3349

Fax: 0621/383-3822

Email: thomas.knoll@uro.ma.uni-heidelberg.de

      >